The scientific world is abuzz … a Nobel Prize-winning technology called CRISPR/Cas9 can now edit our DNA. This programmable gene-editing technology, which is efficient, precise, and scalable, has inspired a gold rush of countless applications in medicine, agriculture and basic science. In this blog we invite you to read more about this ground-breaking advance and how, with one course of treatment, it could potentially cure hereditary transthyretin (hATTR / ATTRv) amyloidosis.
amyloidosis
Charolotte Raymond
AI, Protein Folding & Amyloidosis
Comfort & Connection
On the Other Side of COVID
How are you doing? I mean, how are you really doing? Often we answer automatically with a superficial, “I’m fine, thanks.” Let’s start a long-overdue conversation. Life is hard, and we are not okay. It’s about conversation – open, real discussions on connection and comfort and being part of something bigger. Guest writer Lori Grover shares wonderful and actionable ideas on how to survive the COVID pandemic … together.